IGL Spirits Limited has successfully obtained listing and trading approvals from both the BSE Limited and the National Stock Exchange of India Limited (NSE). These approvals are for the equity shares issued and allotted in connection with the Scheme of Arrangement. The company anticipates the commencement of trading for its equity shares on November 04, 2026.
Stock Exchange Approvals Secured
IGL Spirits Limited (“ISL”) has announced the receipt of crucial Listing and Trading Approvals from the BSE Limited and the National Stock Exchange of India Limited (NSE). This significant development pertains to the equity shares issued and allotted as part of the ongoing Scheme of Arrangement. These approvals pave the way for ISL’s shares to be traded on the public markets.
Key Details of Approval
The approvals, dated November 02, 2026, are specifically for the listing and trading of 6,70,26,765 equity shares, each with a face value of Rs. 5/-. The company has confirmed that trading of these equity shares is set to commence on November 04, 2026. This marks a key milestone for IGL Spirits Limited following its demerger.
Scheme of Arrangement Context
The Scheme of Arrangement involves India Glycols Limited (“Demerged Company”), Ennature Bio Pharma Limited (“Resulting Company 1”), and IGL Spirits Limited (“Resulting Company 2”). The approvals from BSE and NSE are a critical step in fulfilling the conditions stipulated under Sections 230 to 232 of the Companies Act, 2013, related to this arrangement.
Source: BSE
